FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2425189336> ?p ?o ?g. }

• W2425189336 endingPage "e833" @default.
• W2425189336 startingPage "e826" @default.
• W2425189336 abstract "Purpose: To assess pharmacodynamic and safety profiles of ONO-9054 following single and multiple day dosing in subjects with ocular hypertension or open-angle glaucoma. Materials and Methods: This was a phase I, single-center, randomized, double-masked, placebo-controlled dose-escalation study. Nine subjects were randomized to each of ONO-9054 3, 10, 20, 30 μg/mL and 12 to placebo. Subjects received a single drop to each eye at 07:00±30 minutes (single dose). Following a 4-day no-treatment period, subjects were dosed once daily for 14 consecutive days (multiple day dosing). Intraocular pressure (IOP) was measured regularly and compared with baseline measurements. Ocular examinations assessed safety and tolerability. Results: Mean IOP decreased dose dependently. Following single dosing, IOP decreased from 22.9±4.0 to 15.9±2.3 mm Hg (ONO-9054, 30 μg/mL) at peak effect 9 hours postdose; the reduction in placebo-treated subjects was from 22.3±2.4 to 21.5±3.3 mm Hg. Following multiple day dosing, the greatest reduction in IOP occurred 1 hour postdose on day 18, from 23.3±0.6 to 15.1±2.4 mm Hg (ONO-9054, 10 μg/mL); the smallest reduction at this time was from 23.9±0.8 to 18.6±2.0 mm Hg (ONO-9054, 3 μg/mL). Pressures remained reduced on day 19, 25 hours after the last dose, when the lowest measurement was 15.8±2.1 mm Hg (ONO-9054, 10 μg/mL). Anterior uveitis and vitreous detachment were each reported in 2 subjects and considered moderate by the Investigator. Ocular hyperemia and tolerability symptoms were generally mild and transient. Conclusions: ONO-9054 was well-tolerated and elicited dose-dependent reductions in IOP, which were sustained for at least 24 hours following 2 weeks of consecutive daily dosing." @default.
• W2425189336 created "2016-06-24" @default.
• W2425189336 creator A5008173429 @default.
• W2425189336 creator A5008369057 @default.
• W2425189336 creator A5012671046 @default.
• W2425189336 creator A5047069519 @default.
• W2425189336 creator A5076579377 @default.
• W2425189336 creator A5089361326 @default.
• W2425189336 creator A5090356062 @default.
• W2425189336 date "2016-10-01" @default.
• W2425189336 modified "2023-10-04" @default.
• W2425189336 title "Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study" @default.
• W2425189336 cites W1985689227 @default.
• W2425189336 cites W2027733927 @default.
• W2425189336 cites W2042871639 @default.
• W2425189336 cites W2056017055 @default.
• W2425189336 cites W2064517423 @default.
• W2425189336 cites W2105749464 @default.
• W2425189336 cites W2123768500 @default.
• W2425189336 cites W2126688306 @default.
• W2425189336 cites W2128153823 @default.
• W2425189336 cites W2158361549 @default.
• W2425189336 cites W2162221629 @default.
• W2425189336 cites W2163315500 @default.
• W2425189336 cites W2166318934 @default.
• W2425189336 cites W2333746683 @default.
• W2425189336 cites W2406423304 @default.
• W2425189336 cites W2408121173 @default.
• W2425189336 doi "https://doi.org/10.1097/ijg.0000000000000449" @default.
• W2425189336 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27300645" @default.
• W2425189336 hasPublicationYear "2016" @default.
• W2425189336 type Work @default.
• W2425189336 sameAs 2425189336 @default.
• W2425189336 citedByCount "19" @default.
• W2425189336 countsByYear W24251893362016 @default.
• W2425189336 countsByYear W24251893362017 @default.
• W2425189336 countsByYear W24251893362018 @default.
• W2425189336 countsByYear W24251893362019 @default.
• W2425189336 countsByYear W24251893362020 @default.
• W2425189336 countsByYear W24251893362021 @default.
• W2425189336 countsByYear W24251893362022 @default.
• W2425189336 crossrefType "journal-article" @default.
• W2425189336 hasAuthorship W2425189336A5008173429 @default.
• W2425189336 hasAuthorship W2425189336A5008369057 @default.
• W2425189336 hasAuthorship W2425189336A5012671046 @default.
• W2425189336 hasAuthorship W2425189336A5047069519 @default.
• W2425189336 hasAuthorship W2425189336A5076579377 @default.
• W2425189336 hasAuthorship W2425189336A5089361326 @default.
• W2425189336 hasAuthorship W2425189336A5090356062 @default.
• W2425189336 hasBestOaLocation W24251893362 @default.
• W2425189336 hasConcept C111113717 @default.
• W2425189336 hasConcept C112705442 @default.
• W2425189336 hasConcept C118487528 @default.
• W2425189336 hasConcept C126322002 @default.
• W2425189336 hasConcept C126894567 @default.
• W2425189336 hasConcept C141071460 @default.
• W2425189336 hasConcept C142724271 @default.
• W2425189336 hasConcept C168563851 @default.
• W2425189336 hasConcept C197934379 @default.
• W2425189336 hasConcept C204787440 @default.
• W2425189336 hasConcept C27081682 @default.
• W2425189336 hasConcept C2776521421 @default.
• W2425189336 hasConcept C2776740260 @default.
• W2425189336 hasConcept C2777288759 @default.
• W2425189336 hasConcept C2778375690 @default.
• W2425189336 hasConcept C2778527774 @default.
• W2425189336 hasConcept C2781092963 @default.
• W2425189336 hasConcept C42219234 @default.
• W2425189336 hasConcept C71924100 @default.
• W2425189336 hasConceptScore W2425189336C111113717 @default.
• W2425189336 hasConceptScore W2425189336C112705442 @default.
• W2425189336 hasConceptScore W2425189336C118487528 @default.
• W2425189336 hasConceptScore W2425189336C126322002 @default.
• W2425189336 hasConceptScore W2425189336C126894567 @default.
• W2425189336 hasConceptScore W2425189336C141071460 @default.
• W2425189336 hasConceptScore W2425189336C142724271 @default.
• W2425189336 hasConceptScore W2425189336C168563851 @default.
• W2425189336 hasConceptScore W2425189336C197934379 @default.
• W2425189336 hasConceptScore W2425189336C204787440 @default.
• W2425189336 hasConceptScore W2425189336C27081682 @default.
• W2425189336 hasConceptScore W2425189336C2776521421 @default.
• W2425189336 hasConceptScore W2425189336C2776740260 @default.
• W2425189336 hasConceptScore W2425189336C2777288759 @default.
• W2425189336 hasConceptScore W2425189336C2778375690 @default.
• W2425189336 hasConceptScore W2425189336C2778527774 @default.
• W2425189336 hasConceptScore W2425189336C2781092963 @default.
• W2425189336 hasConceptScore W2425189336C42219234 @default.
• W2425189336 hasConceptScore W2425189336C71924100 @default.
• W2425189336 hasIssue "10" @default.
• W2425189336 hasLocation W24251893361 @default.
• W2425189336 hasLocation W24251893362 @default.
• W2425189336 hasLocation W24251893363 @default.
• W2425189336 hasOpenAccess W2425189336 @default.
• W2425189336 hasPrimaryLocation W24251893361 @default.
• W2425189336 hasRelatedWork W2006403852 @default.
• W2425189336 hasRelatedWork W2020609742 @default.
• W2425189336 hasRelatedWork W2032895418 @default.
• W2425189336 hasRelatedWork W2044315218 @default.

• next